BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Video Games for Obesity and Diabetes Prevention-Diab & Nano
Not Applicable
Completed
- Conditions
- ObesityType 2 Diabetes
- Interventions
- Behavioral: G4H-Diab-Nano
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2018-02-20
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 200
- Registration Number
- NCT01846377
- Locations
- 🇺🇸
Children's Nutrition Research Center, Baylor College of Medicine, Houston, Texas, United States
3rd Generation GD-2 Chimeric Antigen Receptor and ICaspase Suicide Safety Switch, Neuroblastoma, GRAIN
Phase 1
Active, not recruiting
- Conditions
- Neuroblastoma
- Interventions
- Genetic: iC9-GD2 T Cells - frozenGenetic: iC9-GD2 T Cells - freshGenetic: iC9-GD2 T cells
- First Posted Date
- 2013-04-02
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 11
- Registration Number
- NCT01822652
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸Houston Methodist Hospital, Houston, Texas, United States
Eosinophilic Esophagitis Clinical Therapy Comparison Trial
Phase 2
Terminated
- Conditions
- Eosinophilic Esophagitis
- Interventions
- Other: Elimination diet
- First Posted Date
- 2013-04-01
- Last Posted Date
- 2021-01-11
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 3
- Registration Number
- NCT01821898
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients
Phase 4
Completed
- Conditions
- HyperglycemiaDiabetes Mellitus
- Interventions
- Drug: Glargine insulinDrug: Lispro insulinDrug: NPH Insulin
- First Posted Date
- 2013-03-14
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 37
- Registration Number
- NCT01810952
- Locations
- 🇺🇸
St. Luke's Episcopal Hospital, Houston, Texas, United States
Effects of Dry Eye Treatments on the Ocular Surface
Phase 4
Completed
- Conditions
- Dry Eye SyndromeKeratoconjunctivitis Sicca
- Interventions
- Drug: Artificial tear
- First Posted Date
- 2013-02-25
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT01797822
- Locations
- 🇺🇸
Baylor College of Medicine, Alkek Eye Center, Houston, Texas, United States
Pentoxifylline Therapy in Biliary Atresia
- First Posted Date
- 2013-01-24
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 17
- Registration Number
- NCT01774487
- Locations
- 🇺🇸
Texas Children's Hospital and Baylor College of Medicine, Houston, Texas, United States
Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies
Early Phase 1
Completed
- Conditions
- Diffuse Large B Cell LymphomaPrimary Mediastinal (Thymic) Large B-cell LymphomaPost Transplant Lymphoproliferative Disorder
- Interventions
- Drug: DA-EPOCH-R for DLBCL, PTLD, AND PMBCL
- First Posted Date
- 2013-01-04
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 4
- Registration Number
- NCT01760226
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Treatment of Subarachnoid Hemorrhage With Human Albumin
- First Posted Date
- 2012-12-11
- Last Posted Date
- 2012-12-11
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 47
- Registration Number
- NCT01747408
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Validation of a Digital Diet Method for Use With Preschoolers
Completed
- Conditions
- Feeding Behaviors
- First Posted Date
- 2012-11-12
- Last Posted Date
- 2017-07-12
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 94
- Registration Number
- NCT01725347
- Locations
- 🇺🇸
USDA/ARS Children's Nutrition Research Center, Houston, Texas, United States
Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults
Phase 1
Completed
- Conditions
- Hookworm InfectionHookworm Disease
- Interventions
- Biological: Na-APR-1 (M74)/Alhydrogel®Biological: Gluco-Pyranosylphospho-Lipid A Aqueous Formulation
- First Posted Date
- 2012-10-31
- Last Posted Date
- 2019-07-31
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT01717950
- Locations
- 🇺🇸
George Washington University Medical Faculty Associates, Washington, District of Columbia, United States
© Copyright 2025. All Rights Reserved by MedPath